DSGN
Design Therapeutics Inc
12.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | – | – | |
| 0.2% | 2,212.4% | – | – | – | – | – | |
| -0.1% | -2,212.4% | – | – | – | – | – | |
| 198.3% | 2,681,415.9% | – | – | – | – | – | |
| 130.5% | 1,104,424.8% | – | – | – | – | – | |
| 228.8% | 3,783,628.3% | – | – | – | – | – | |
| -228.8% | -3,785,840.7% | – | – | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | |
| -245.4% | -3,663,716.8% | – | – | – | – | – | |
| 16.7% | -89,069.5% | – | – | – | – | – | |
| -245.4% | -3,663,716.8% | – | – | – | – | – | |
| -228.8% | -3,661,504.4% | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.